Pinnacle Associates’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,750
| Closed | -$389K | – | 820 |
|
|
2023
Q3 | $389K | Hold |
14,750
| – | – | 0.01% | 603 |
|
|
2023
Q2 | $254K | Hold |
14,750
| – | – | ﹤0.01% | 724 |
|
|
2023
Q1 | $245K | Sell |
14,750
-28,750
| -66% | -$477K | 0.01% | 678 |
|
|
2022
Q4 | $331K | Sell |
43,500
-3,237
| -7% | -$24.7K | 0.01% | 582 |
|
|
2022
Q3 | $465K | Sell |
46,737
-5,350
| -10% | -$53.2K | 0.01% | 507 |
|
|
2022
Q2 | $473K | Hold |
52,087
| – | – | 0.01% | 527 |
|
|
2022
Q1 | $529K | Hold |
52,087
| – | – | 0.01% | 547 |
|
|
2021
Q4 | $869K | Sell |
52,087
-200
| -0.4% | -$3.34K | 0.02% | 478 |
|
|
2021
Q3 | $2.45M | Hold |
52,287
| – | – | 0.05% | 309 |
|
|
2021
Q2 | $3.19M | Buy |
+52,287
| New | +$3.19M | 0.06% | 276 |
|
|
2020
Q3 | – | Sell |
-51,044
| Closed | -$1.67M | – | 679 |
|
|
2020
Q2 | $1.67M | Buy |
+51,044
| New | +$1.67M | 0.04% | 297 |
|
|
2020
Q1 | – | Sell |
-5,800
| Closed | -$203K | – | 659 |
|
|
2019
Q4 | $203K | Buy |
+5,800
| New | +$203K | ﹤0.01% | 666 |
|